Address:

90 BRIDGE STREET

NEWTON, MA 02458

Phone:

617-396-4329

Email:

info@labshares.com

Follow us on social media:

  • LinkedIn
  • Twitter
  • Facebook
  • YouTube
  • Pinterest
  • Yelp
  • Reddit logo
  • Quora logo

© 2020 LabShares Newton

Screenshot 2019-03-13 09.28.12.png

Siamab Therapeutics

Siamab Therapeutics is a biopharmaceutical company developing therapies targeting cancers that express abnormal carbohydrates/glycans.

 

They have developed a technology platform that enables the discovery of large numbers of highly specific, high-affinity anti-TACA therapeutic antibodies.

 

Siamab has brought together a leading team of scientists and advisors in oncology, glycoimmunology, and antibody engineering to support our anti-TACA antibody discovery and development programs.